Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3078 studies found for:    "Hepatitis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Hepatitis C: Grading and Staging by MR
Condition: Hepatitis
Intervention:
2 Completed Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children
Condition: Hepatitis A
Intervention: Biological: hepatitis A vaccine
3 Completed The Effects of Honey, as a Dietary Supplement in Children With Hepatitis A
Condition: Hepatitis A
Interventions: Dietary Supplement: honey;   Dietary Supplement: molasses
4 Completed Hepatitis C Testing in VA Community-Based Outpatient Clinics
Condition: Hepatitis C
Intervention: Other: QI
5 Recruiting The Hepatitis Delta International Network
Condition: Hepatitis D
Intervention:
6 Completed Undiagnosed Hepatitis C Infection in an Urban Hospital
Condition: Hepatitis C
Intervention: Other: Observation only, no intervention
7 Completed Australian Trial in Acute Hepatitis C
Condition: Hepatitis C
Interventions: Drug: Pegylated Interferon alfa 2a;   Drug: Ribavirin (HIV conifected patients only)
8 Completed Hepatitis A Vaccination in the Elderly
Condition: Hepatitis A
Intervention:
9 Completed Pegaferon and Ribavirin for Hepatitis C
Condition: Hepatitis C
Intervention: Drug: Pegaferon (pegylated interferon alpha 2a) + ribavirin
10 Terminated Autoimmune Hepatitis Study
Condition: Hepatitis, Autoimmune
Intervention:
11 Recruiting Immune Cell Dysfunction in Severe Alcoholic Hepatitis
Condition: Hepatitis
Intervention:
12 Completed Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U)
Condition: Hepatitis A
Intervention:
13 Unknown  Antigen-specific Immune Response to Hepatitis B Virus in Utero
Condition: Hepatitis B
Intervention:
14 Unknown  Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg Negative
Condition: Hepatitis B
Intervention:
15 Completed A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)
Condition: Hepatitis E
Intervention: Biological: Recombinant Hepatitis E Vaccine (Escherichia Coli)
16 Completed A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A
Condition: Hepatitis A
Intervention: Biological: Hepatitis A vaccine
17 Completed
Has Results
Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C
Condition: Hepatitis C
Interventions: Drug: BMS-790052 (NS5A Replication Complex Inhibitor);   Drug: Placebo matching BMS-790052;   Drug: Pegylated-interferon alfa 2a;   Drug: Ribavirin
18 Completed
Has Results
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule
Condition: Hepatitis A
Intervention: Biological: Havrix™
19 Completed
Has Results
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule
Condition: Hepatitis A
Intervention: Biological: Havrix™
20 Completed
Has Results
Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients
Condition: Hepatitis C
Intervention: Drug: Alisporivir

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.